Your browser doesn't support javascript.
loading
Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors.
Beg, Muhammad S; Brenner, Andrew J; Sachdev, Jasgit; Borad, Mitesh; Kang, Yoon-Koo; Stoudemire, Jay; Smith, Susan; Bader, Andreas G; Kim, Sinil; Hong, David S.
Afiliación
  • Beg MS; Division of Hematology/Oncology, University of Texas (UT) Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390-8852, USA. Muhammad.Beg@UTSouthwestern.edu.
  • Brenner AJ; UT Health Science Center, San Antonio, TX, USA.
  • Sachdev J; Scottsdale Healthcare Research Institute, Scottsdale, AZ, USA.
  • Borad M; Mayo Clinic Cancer Center, Scottsdale, AZ, USA.
  • Kang YK; Asan Medical Center, Seoul, South Korea.
  • Stoudemire J; Mirna Therapeutics, Inc, Austin, TX, USA.
  • Smith S; Mirna Therapeutics, Inc, Austin, TX, USA.
  • Bader AG; Mirna Therapeutics, Inc, Austin, TX, USA.
  • Kim S; Mirna Therapeutics, Inc, Austin, TX, USA.
  • Hong DS; UT MD Anderson Cancer Center, Houston, TX, USA.
Invest New Drugs ; 35(2): 180-188, 2017 04.
Article en En | MEDLINE | ID: mdl-27917453
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: MicroARNs / Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: MicroARNs / Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos